AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Sundry Debtors | ₹5,746 Cr | ₹4,817 Cr | ₹4,466 Cr | ₹4,012 Cr | ₹3,503 Cr |
What is the latest Sundry Debtors ratio of AUROBINDO PHARMA ?
Year | Sundry Debtors |
---|---|
Mar2025 | ₹5,746 Cr |
Mar2024 | ₹4,817 Cr |
Mar2023 | ₹4,466 Cr |
Mar2022 | ₹4,012 Cr |
Mar2021 | ₹3,503 Cr |
How is Sundry Debtors of AUROBINDO PHARMA Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2025 | ₹5,746 Cr | 19.29 | |
Mar2024 | ₹4,817 Cr | 7.84 | |
Mar2023 | ₹4,466 Cr | 11.32 | |
Mar2022 | ₹4,012 Cr | 14.53 | |
Mar2021 | ₹3,503 Cr | - |
Compare Sundry Debtors of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹60,127.3 Cr | 0.7% | -5.1% | -33.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹379,659.0 Cr | -0.7% | -3.6% | -13.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,886.0 Cr | 0.3% | -5.5% | 22.4% | Stock Analytics | |
CIPLA | ₹127,435.0 Cr | -0.8% | 4.1% | -4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,719.0 Cr | 1.1% | -0.5% | 5.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,610.0 Cr | -0.8% | 2.3% | -8.1% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 0.7% |
-5.1% |
-33.4% |
SENSEX | 0.8% |
0.2% |
-2% |
You may also like the below Video Courses